BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2929747)

  • 1. HPA axis hyperactivity and recovery from functional psychoses.
    Coryell WH; Zimmerman M
    Am J Psychiatry; 1989 Apr; 146(4):473-7. PubMed ID: 2929747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 3. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.
    Vreeburg SA; Hoogendijk WJ; DeRijk RH; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1494-502. PubMed ID: 23313277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up.
    Coryell W; Tsuang D
    Am J Psychiatry; 1992 Aug; 149(8):1033-9. PubMed ID: 1636802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress and HPA-axis functioning in young people at ultra high risk for psychosis.
    Thompson KN; Phillips LJ; Komesaroff P; Yuen HP; Wood SJ; Pantelis C; Velakoulis D; Yung AR; McGorry PD
    J Psychiatr Res; 2007 Oct; 41(7):561-9. PubMed ID: 16831447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
    Meador-Woodruff JH; Gurguis G; Grunhaus L; Haskett RF; Greden JF
    Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis.
    Belvederi Murri M; Pariante CM; Dazzan P; Hepgul N; Papadopoulos AS; Zunszain P; Di Forti M; Murray RM; Mondelli V
    Psychoneuroendocrinology; 2012 May; 37(5):629-44. PubMed ID: 21930345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of endogenous cortisol to psychiatric disorder: a review.
    Kiraly SJ; Ancill RJ; Dimitrova G
    Can J Psychiatry; 1997 May; 42(4):415-20. PubMed ID: 9161767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test in geriatric depression.
    Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE
    Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207
    [No Abstract]   [Full Text] [Related]  

  • 15. [The dexamethasone suppression test in depression. Critical review].
    Bailly D; Goudemand M; Parquet PJ
    Encephale; 1984; 10(4):155-69. PubMed ID: 6389093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 17. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
    Schatzberg AF
    World J Biol Psychiatry; 2015 Jan; 16(1):2-11. PubMed ID: 24933348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
    Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPA axis function and temperament in depression: a negative report.
    Roy A
    Biol Psychiatry; 1996 Mar; 39(5):364-6. PubMed ID: 8704068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.